×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GH – guardant health, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
08:09 am
gh
Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care [Yahoo! Finance]
Low
Report
Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care [Yahoo! Finance]
12/20
08:05 am
gh
Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Low
Report
Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
12/19
06:16 am
gh
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics [Yahoo! Finance]
Low
Report
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics [Yahoo! Finance]
12/19
06:00 am
gh
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
Medium
Report
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
12/18
08:14 am
gh
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer [Yahoo! Finance]
Medium
Report
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer [Yahoo! Finance]
12/18
08:05 am
gh
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Medium
Report
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
12/10
10:43 am
gh
Minimal Residual Disease Market to Hit USD 2.55 Billion by 2029 with 12.2% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Minimal Residual Disease Market to Hit USD 2.55 Billion by 2029 with 12.2% CAGR | MarketsandMarkets™ [Yahoo! Finance]
12/10
09:43 am
gh
Rafay Delivers FIPS-compliant Self-hosted Controller to Address Public Sector Demand [Yahoo! Finance]
Low
Report
Rafay Delivers FIPS-compliant Self-hosted Controller to Address Public Sector Demand [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/19
06:30 pm
gh
Form 4 Guardant Health, Inc. For: Dec 18 Filed by: Tariq Musa
Low
Report
Form 4 Guardant Health, Inc. For: Dec 18 Filed by: Tariq Musa
12/18
04:38 pm
gh
Form 144 Guardant Health, Inc. Filed by: Tariq Musa
Low
Report
Form 144 Guardant Health, Inc. Filed by: Tariq Musa
12/16
06:28 pm
gh
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Saia John G.
Low
Report
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Saia John G.
12/16
06:27 pm
gh
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: POTTER MYRTLE S
Low
Report
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: POTTER MYRTLE S
12/16
06:26 pm
gh
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Kalia Kumud
Low
Report
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Kalia Kumud
12/16
06:16 pm
gh
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Freeman Chris
Low
Report
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Freeman Chris
12/16
06:15 pm
gh
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: EAGLE CRAIG
Low
Report
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: EAGLE CRAIG
12/16
06:13 pm
gh
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Bell Michael Brian
Low
Report
Form 4 Guardant Health, Inc. For: Dec 15 Filed by: Bell Michael Brian
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/6
Q2/2019 6/30/2019 EPS -0.130 ZacksConsensus -0.340 ActVsEst 0.210 - Beat
20.5%
5/9 Q1/2019 3/31/2019 EPS -0.300 ZacksConsensus -0.350 ActVsEst 0.050 - Beat 18.6%
2/27 Form 4 Guardant Health, Inc. For: Feb 25 Filed by: CLARK IAN T 12.9%
3/3 Form 4 Guardant Health, Inc. For: Feb 28 Filed by: Nishar Dipchand 12.4%
11/7 Q3/2019 9/30/2019 EPS -0.140 ZacksConsensus -0.390 ActVsEst 0.250 - Beat 12.2%
3/25 Form 4 Guardant Health, Inc. For: Mar 23 Filed by: BERTOCCI DEREK A 8.0%
2/25 Guardant Health Inc (GH) Q4 2019 Earnings Call Transcript [The Motley Fool] 7.5%
5/23 Form EFFECT Guardant Health, Inc. 6.5%
2/11 Form 4/A Guardant Health, Inc. For: Dec 20 Filed by: Talasaz AmirAli 6.3%
4/9 Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhibitors in Women with HR+ Metastatic Breast Cancer 6.3%
5/9 Q1/2019 3/31/2019 EPS -0.300 ZacksConsensus -0.350 ActVsEst 0.050 - Beat 18.6%
2/27 Form 4 Guardant Health, Inc. For: Feb 25 Filed by: CLARK IAN T 12.9%
3/3 Form 4 Guardant Health, Inc. For: Feb 28 Filed by: Nishar Dipchand 12.4%
11/7 Q3/2019 9/30/2019 EPS -0.140 ZacksConsensus -0.390 ActVsEst 0.250 - Beat 12.2%
3/25 Form 4 Guardant Health, Inc. For: Mar 23 Filed by: BERTOCCI DEREK A 8.0%
2/25 Guardant Health Inc (GH) Q4 2019 Earnings Call Transcript [The Motley Fool] 7.5%
5/23 Form EFFECT Guardant Health, Inc. 6.5%
2/11 Form 4/A Guardant Health, Inc. For: Dec 20 Filed by: Talasaz AmirAli 6.3%
4/9 Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhibitors in Women with HR+ Metastatic Breast Cancer 6.3%
TOP News Decliners
3/15
Coronavirus Bear Market: Where to Invest $5,000 Right Now [The Motley Fool]
-12.6%
3/6 Form 4 Guardant Health, Inc. For: Mar 04 Filed by: Kaul Samir -11.3%
2/24 Q4/2019 12/31/2019 EPS -0.270 ZacksConsensus -0.300 ActVsEst 0.030 - Beat -10.2%
2/28 Form 4 Guardant Health, Inc. For: Feb 26 Filed by: Kaul Samir -9.2%
5/8 The Wall Street Journal: SoftBank’s Vision Fund positioned for big haul in Uber IPO [MarketWatch] -7.5%
8/8 Guardant Health Inc (NASDAQ: GH) was given a new $110.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. -6.9%
5/10 Form 4 Guardant Health, Inc. For: May 10 Filed by: BERTOCCI DEREK A -6.0%
3/11 Guardant Health Inc (NASDAQ: GH) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.0%
10/5 3 Top Healthcare Stocks to Buy in October [The Motley Fool] -6.0%
9/13 Form 4 Guardant Health, Inc. For: Sep 11 Filed by: SVF Endurance (Cayman) Ltd -5.7%
3/6 Form 4 Guardant Health, Inc. For: Mar 04 Filed by: Kaul Samir -11.3%
2/24 Q4/2019 12/31/2019 EPS -0.270 ZacksConsensus -0.300 ActVsEst 0.030 - Beat -10.2%
2/28 Form 4 Guardant Health, Inc. For: Feb 26 Filed by: Kaul Samir -9.2%
5/8 The Wall Street Journal: SoftBank’s Vision Fund positioned for big haul in Uber IPO [MarketWatch] -7.5%
8/8 Guardant Health Inc (NASDAQ: GH) was given a new $110.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. -6.9%
5/10 Form 4 Guardant Health, Inc. For: May 10 Filed by: BERTOCCI DEREK A -6.0%
3/11 Guardant Health Inc (NASDAQ: GH) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.0%
10/5 3 Top Healthcare Stocks to Buy in October [The Motley Fool] -6.0%
9/13 Form 4 Guardant Health, Inc. For: Sep 11 Filed by: SVF Endurance (Cayman) Ltd -5.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: